Related Experiment Video
Updated: Aug 30, 2026

A Protocol for Analyzing Hepatitis C Virus Replication
Published on: June 26, 2014
Management of newly diagnosed hepatitis C virus infection
Mark W Russo1, Steven L Zacks, Michael W Fried
1Division of Gastroenterology and Hepatology, University of North Carolina at Chapel Hill, USA.
Abstract:
All patients with chronic hepatitis C virus infection are potential candidates for antiviral therapy. Careful patient selection can optimize the response to therapy and enhance safety. Pegylated forms of interferon, when combined with ribavirin, can "cure" the majority of patients undergoing therapy, and these agents have become the new standard of care for chronic hepatitis C. Careful and timely management of side effects, which are experienced by all patients, can improve adherence to antiviral therapy and further improve response rates.
Related Concept Videos
Hepatitis
Viral Hepatitis I: Introduction
Esophageal Varices-II: Clinical Features and Management
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol abuse, or...
Retrovirus Life Cycles
Cystic Fibrosis: Management
Sinus disease and chronic sinusitis...
Antiviral Nucleoside Inhibitors
